SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-045332
Filing Date
2019-09-20
Accepted
2019-09-20 06:30:13
Documents
1
Group Members
CCP IV GP LTD.CITIC CAPITAL CHINA PARTNERS IV, L.P.CITIC CAPITAL PARTNERS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv529765_sc13da.htm SC 13D/A 117335
  Complete submission text file 0001144204-19-045332.txt   119279
Mailing Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125
Business Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125 86-10-6598-3111
China Biologic Products Holdings, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 191102644
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 28/F, CITIC TOWER, 1 TIM MEI AVENUE, CENTRAL K3 00000
Business Address 28/F, CITIC TOWER, 1 TIM MEI AVENUE, CENTRAL K3 00000 852-3710-6888
CITIC Capital Holdings Ltd (Filed by) CIK: 0001677151 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A